alexa Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy | Open Access Journals
ISSN: 2472-1115
Journal of Down Syndrome & Chromosome Abnormalities
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy

Isa Abdi Rad*

Department of Medical Genetics, Motahari Teaching Hospital, Urmia University of Medical Sciences, Kashani Street, Urmia, West Azerbaijan, Iran

*Corresponding Author:
Isa Abdi Rad
Professor of Neurogenetics
Department of Medical Genetics
Motahari Teaching Hospital, Urmia University of Medical Sciences
Kashani Street, Urmia, West Azerbaijan, Iran
Tel: 0914 440 5829
E-mail: [email protected]

Received date: March 14, 2017; Accepted date: March 22, 2017; Published date: March 29, 2017

Citation: Rad IA (2017) Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy. J Down Syndr Chr Abnorm 3:118. doi:10.4172/2472-1115.1000118

Copyright: © 2017 Rad IA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Down Syndrome & Chromosome Abnormalities


Spinal muscular atrophy (SMA) is an autosomal recessive disease and characterized by symmetrical muscle weakness. All types of SMA are the result of mutations in survival motor neuron (SMN1) gene. Although, mutations in SMN1 gene are essential for pathogenesis of the disease, copy number variation in SMN2 are related to the age of onset and the severity of disease. The most common mutation on the SMN1 is homozygous deletion of exon 7 that is seen in 95%-98% of patients, followed by compound heterozygous for a deletion of exon 7 and a point mutation in the another allele of SMN1 which is seen in 2%-5% of cases. SMA patients with homozygous point mutation in SMN1 gene reported very rarely.


Spinal muscular atrophy; SMN1 gene; Homozygous point mutation; Copy number

Clinical Aspects of SMA

Spinal muscular atrophy (SMA), with an incidence of 1/10000 world-wide [1,2] is a lower motor neuron disease and characterized by symmetrical muscle weakness and atrophy resulting from progressive degeneration of alpha motor neurons and loss of the anterior horn cells in the spinal cord and the brain stem nuclei. The inheritance pattern of SMA is autosomal recessive and classified clinically into the following types, based on the age at onset and clinical severity: SMA 0 (prenatal onset), SMA I (Werdnig-Hoffmann disease with onset before age 6 months), SMA II (Dubowitz disease with onset between age 6 and 18 months), SMA III (Kugelberg-Welander disease with onset after age 18 months), and SMA IV (onset after age 18 years). After unraveling the genetic basis of SMA, all SMN1-associated clinical types can be considered as a continuum without a clear delineation.

Survival Motor Neuron (SMN) Gene

Survival motor neuron (SMN) gene, the SMA determining gene, located on 5q12.2-q13.3 with two homologue copies, SMN1 (survival motor neuron 1; telomeric copy) and SMN2 (survival motor neuron 2; centromeric copy), which differ by only eight nucleotide (five are intronic and three are exonic, located within exons 6, 7, and 8) [3-6]. SMN1 and SMN2, both containing nine exons with 99% nucleotide identity, are arranged in tandem on each chromosome encoding a 294-amino acid RNA-binding protein. One of the coding sequence of SMN2 that differs from that of SMN1 by a single nucleotide (840 C>T) results in alternative splicing of exon 7 [4]. Due to the alternative splicing of exon 7, SMN2 genes produce a reduced amount of full length transcripts, and a variable amount of mRNA lacking exon 7, which give raise to a truncated and unstable protein [7], whereas SMN1 produces full-length transcripts.

Full-length product of SMN1 is necessary for lower motor neuron function and loss of SMN1 is essential to the pathogenesis of SMA, while SMN2 copy number modifies the severity of phenotype.

Copy Number Variation of SMN2 Gene

The number of SMN2 copies (arranged in tandem in cis configuration on each chromosome) ranges from zero to five that can be detected using quantitative PCR and MLPA methods [8,9]. The presence of three or more copies of SMN2 is associated with a milder phenotype [10-13]. All SMA patients retain at least one copy of SMN2, so, SMA is caused by low levels of SMN protein rather than complete absence of the protein. Most SMA type I patients have two copies of SMN2, three SMN2 copies are common in SMA type II, while type III and IV generally have three or four copies. On the other hand, no correlation exists between the loss of SMN1 exon 7 and the severity of disease, that is, the homozygous exon 7 deletions is observed with the same frequency in all phenotypes.

Mutation Spectrum of SMN1 Gene

Approximately 95%-98% of all types of SMA patients show homozygous deletion of SMN1 exon 7 (and exon 8 in the majority of cases) [14-16]. Approximately 6% of parents of a child with homozygous SMN1 deletion have normal results of SMN1 copy number testing because 4% of carriers have two copies of SMN1 on a single chromosome and a deletion on the other chromosome [14,17] and also de novo deletion of exon 7 of one SMN1 allele occurs in 2% of individuals with SMA [18].

Only 2-5% of SMA patients are compound heterozygous, that is, deletion of exon 7 (and exon 8) on one of their alleles and an intragenic point mutation of the SMN1 gene on the another allele [19-23]. Point mutations are dispersed all over the SMN1 gene; however, most of them are located in exons six and three that encode self-oligomerization and Tudor domains of SMN protein, respectively [24-26]. These subtle pathogenic mutations in SMN1 include base substitutions resulting in amino acid changes, splice site alterations, termination codons, and small insertions or deletions resulting in frame-shift [20,27,28]. Although, more than 60 subtle mutations of SMN1 gene have been reported worldwide [22], homozygous subtle mutations are very rarely reported in patients with SMA. Kirwin et al. reported homozygous double mutation in a SMA patient [29] and Rad et al. reported homozygous point mutation (c.549delC at exon 5) which resulted in fame-shift on SMN1 gene in a SMA type I patient [30].These reports imply that although DNA sequencing is routinely carried out on SMA patient with only one copy of SMN1 gene, it should also be carried out in patients with clinical diagnosis of SMA who show even two copies of SMN1 gene [31].


One of the following mutation conditions can occur on the SMN1 gene in the SMA patients:

1. Homozygous deletion of exon 7 (with or without deletion of exon 8) (95%-98% of cases)

2. Compound heterozygous for a deletion of exon 7 and a point mutation (2%-5% of cases)

3. Homozygous for a subtle or point mutation (very rare)


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 263
  • [From(publication date):
    June-2017 - Sep 26, 2017]
  • Breakdown by view type
  • HTML page views : 231
  • PDF downloads :32

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version